{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-055725","form_type":"8-K","ticker":"DERM","cik":"0001867066","company_name":"Journey Medical Corp","filed_at":"2024-05-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.990250+00:00","generated_at":"2026-06-03T03:16:16.610414+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Journey Medical appoints Joseph Benesch as permanent CFO effective April 26","bullets":["Mr. Benesch had served as interim CFO since January 2023 and as Corporate Controller since November 2021.","Compensation remains unchanged; any future changes will be determined by Board/Compensation Committee.","Benesch brings over 25 years of public/private accounting and life sciences experience, including prior CFO roles at Teligent and Torrent.","CEO Claude Maraoui cited Benesch's leadership as key for upcoming milestones, including potential DFD-29 FDA decision for rosacea."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-055725","json":"https://secwatch.observer/filing/0001104659-24-055725.json","markdown":"https://secwatch.observer/filing/0001104659-24-055725.md","text":"https://secwatch.observer/filing/0001104659-24-055725.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/0001104659-24-055725-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/tm2413228d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T03:16:16.610414+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"af94387750","claim":"Joseph Benesch was appointed as Chief Financial Officer at Journey Medical Corp.","evidence_excerpt":"On April 26, 2024, the Board of Directors (the “ Board ”) of Journey Medical Corporation (the “ Company ”) appointed Joseph Benesch, age 57, as the Company’s permanent Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1867066/000110465924055725/0001104659-24-055725-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}